share_log

華領醫藥-B：股份發行人的證券變動月報表

HUA MEDICINE-B: Monthly Return of Equity Issuer on Movements in Securities

香港交易所 ·  Jan 5 03:31
Summary by Moomoo AI
華領醫藥-B（股份代號：02552）於2024年1月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2023年12月31日的公司股份變動情況。報告顯示，華領醫藥的法定/註冊股本及已發行股份在報告期內均無變動，法定/註冊股本結存為2,000,000,000股，每股面值0.001美元，總額為2,000,000美元。已發行股份結存為1,055,588,761股。此外，根據公司股份期權計劃，截至本月底，公司有53,797,568股股份期權尚未行使，若全部行使將可能發行新股份43,323,276股。公司確認所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
華領醫藥-B（股份代號：02552）於2024年1月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2023年12月31日的公司股份變動情況。報告顯示，華領醫藥的法定/註冊股本及已發行股份在報告期內均無變動，法定/註冊股本結存為2,000,000,000股，每股面值0.001美元，總額為2,000,000美元。已發行股份結存為1,055,588,761股。此外，根據公司股份期權計劃，截至本月底，公司有53,797,568股股份期權尚未行使，若全部行使將可能發行新股份43,323,276股。公司確認所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
HUA LIN PHARMACEUTICAL-B (STOCK CODE: 02552) FILED ITS LATEST SECURITIES MONTH CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 5 JANUARY 2024, REPORTING THE CHANGES IN THE COMPANY'S SHARES FOR THE YEAR ENDED 31 DECEMBER 2023. THE REPORT SHOWS THAT THE STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES OF HUALIN PHARMACEUTICALS WERE UNCHANGED DURING THE REPORTING PERIOD. THE STATUTORY/REGISTERED SHARE CAPITAL WAS 2,000,000,000 SHARES WITH A FACE VALUE OF $0.001 PER SHARE FOR A TOTAL AMOUNT OF $2,000,000. The issued shares were deposited at 1,055,588,761 shares. In addition, under the Company's stock option plan, as of the end of this month, the Company had 53,797,568 share options outstanding and 43,323,276 shares may be issued if all exercised. The Company confirms that all securities issuance has been approved by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
HUA LIN PHARMACEUTICAL-B (STOCK CODE: 02552) FILED ITS LATEST SECURITIES MONTH CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 5 JANUARY 2024, REPORTING THE CHANGES IN THE COMPANY'S SHARES FOR THE YEAR ENDED 31 DECEMBER 2023. THE REPORT SHOWS THAT THE STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES OF HUALIN PHARMACEUTICALS WERE UNCHANGED DURING THE REPORTING PERIOD. THE STATUTORY/REGISTERED SHARE CAPITAL WAS 2,000,000,000 SHARES WITH A FACE VALUE OF $0.001 PER SHARE FOR A TOTAL AMOUNT OF $2,000,000. The issued shares were deposited at 1,055,588,761 shares. In addition, under the Company's stock option plan, as of the end of this month, the Company had 53,797,568 share options outstanding and 43,323,276 shares may be issued if all exercised. The Company confirms that all securities issuance has been approved by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more